Julie M Mazet, Postdoctoral Researcher at Ludwig Cancer Research, shared a post on LinkedIn:
“Honoured and excited to have presented our research at the European Association for Cancer Research (EACR) 2026 Congress in Budapest as part of the Award Winners Special Session yesterday.
I am grateful to The Mark Foundation for Cancer Research and EACR for their support through the Postdoctoral Fellowship and for the opportunity to share our work on unlocking CD8+ T cell anti-tumour activity in brain metastasis.
Brain metastases remain a major clinical challenge, and I am excited to discuss our efforts to better understand and overcome T cell dysfunction in this context.
A big thank you to all the colleagues, and collaborators who have contributed to this first year of work. Special thanks to Prof Johanna Joyce and the entire team for creating an environment where ambitious science can thrive.
Looking forward to a week of inspiring science, new ideas and stimulating discussions. If you are attending EACR2026, I would be delighted to connect!”
Other articles featuring Johanna Joyce on OncoDaily.